BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion (Q39439117)

12 September 2017

title

BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion (English)

1 reference

12 September 2017

main subject

papillary thyroid cancer

1 reference

Avik Chakraborty

1

1 reference

12 September 2017

Archana Narkar

2

1 reference

12 September 2017

Rita Mukhopadhyaya

3

1 reference

12 September 2017

Shubhada Kane

4

1 reference

12 September 2017

Anil D'Cruz

5

1 reference

12 September 2017

M G R Rajan

6

1 reference

12 September 2017

publication date

1 June 2012

1 reference

12 September 2017

1 reference

12 September 2017

volume

23

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

83-93

1 reference

https://scigraph.springernature.com/pub.10.1007/s12022-011-9184-5

12 September 2017

exact match

0 references

cites work

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

RET/PTC rearrangement in thyroid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

BRAF mutation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

The prevalence and prognostic value of BRAF mutation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

BRAF(V600E) mutation and the biology of papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

High BRAF mutation frequency does not characterize all melanocytic tumor types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

T1799A BRAF mutations in conjunctival melanocytic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Guilty as charged: B-RAF is a human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Pathogenetic mechanisms in thyroid follicular-cell neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

B-Raf-dependent regulation of the MEK-1/mitogen-activated protein kinase pathway in PC12 cells and regulation by cyclic AMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9184-5

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

21 January 2018

1 reference

12 December 2020

Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis

1 reference

12 December 2020

1 reference

12 December 2020

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma

1 reference

12 December 2020

Molecular mechanisms of RET activation in human cancer.

1 reference

12 December 2020

Thyroid cancer in Wales 1985-1996: a cancer registry-based study

1 reference

12 December 2020

Descriptive epidemiology of thyroid cancer in greater Bombay.

1 reference

12 December 2020

10.1007/S12022-011-9184-5

Identifiers

DOI

1 reference

12 September 2017

1 reference